SCHEMBL12428445

SCHEMBL12428445

CC1(C)c2cc(/C=C3\C(=O)N(c4ccccc4)N=C3C(=O)O)ccc2-c2ccc(-c3ccc4c(c3)CCCN4c3ccccc3)cc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 8/20 0.36
MEN1 O00255 7/20 0.36
ALDH1A1 P00352 5/20 0.36
MAPT P10636 5/20 0.36
KDM4E B2RXH2 3/20 0.36
GAA P10253 3/20 0.36
TDP1 Q9NUW8 2/20 0.36
RECQL P46063 2/20 0.36
POLB P06746 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
GALK1 P51570 1/20 0.36
BLM P54132 1/20 0.36
HPGD P15428 3/20 0.36
KAT8 Q9H7Z6 1/20 0.35
THRB P10828 1/20 0.35
SCN9A Q15858 1/20 0.35
TDP2 O95551 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HKDC1 Q2TB90 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12428439 0.94 KMT2A (0.37) KMT2AMEN1ALDH1A1MAPTKDM4E
SCHEMBL12428140 0.89 KAT8 (0.37) KMT2AMEN1ALDH1A1MAPTKDM4E
SCHEMBL12428446 0.88 MEN1 (0.42) KMT2AMEN1ALDH1A1MAPTKDM4E
SCHEMBL12428447 0.88 MEN1 (0.42) KMT2AMEN1ALDH1A1MAPTKDM4E
SCHEMBL12428117 0.85 ALDH1A1 (0.44) KMT2AMEN1ALDH1A1MAPTKDM4E
SCHEMBL12428169 0.85 ALDH1A1 (0.44) KMT2AMEN1ALDH1A1MAPTKDM4E
SCHEMBL12428121 0.84 KAT8 (0.45) KMT2AMEN1ALDH1A1MAPTKDM4E
SCHEMBL12428443 0.83 TDP2 (0.38) KMT2AMEN1ALDH1A1MAPTKDM4E
SCHEMBL12428202 0.83 KAT8 (0.43) KMT2AMEN1ALDH1A1MAPTKDM4E
SCHEMBL12428177 0.83 KMT2A (0.43) KMT2AMEN1ALDH1A1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977570-B2 Dye-sensitized photoelectric conversion device NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2011-07-12 US disclosed
US-7977570-B2 Dye-sensitized photoelectric conversion device NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2011-07-12 US disclosed
US-20090084441-A1 Dye-sensitized photoelectric conversion device NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2009-04-02 US disclosed
US-20090084441-A1 Dye-sensitized photoelectric conversion device NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2009-04-02 US disclosed
EP-1885015-A1 DYE-SENSITIZED PHOTOELECTRIC CONVERSION DEVICE Nippon Kayaku Kabushiki Kaisha (JP) 2008-02-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090084441-A1 Dye-sensitized photoelectric conversion device CRY1, H1-5, H1-0 KMT2A 105/4885MEN1 251/4885ALDH1A1 235/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.